1 / 7

Why TARE is effective treatment option for hepatocellular carcinoma

Why Transarterial Radioembolization (TARE) is effective treatment option for hepatocellular carcinoma. And when compared to standard radiation therapy, is TARE has any side-effects. Details available in PPT

ManavSadhwani
Download Presentation

Why TARE is effective treatment option for hepatocellular carcinoma

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. TRANSARTERIAL RADIOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA

  2. Transarterial Radioembolization (TARE), is an emerging and promising therapy for the treatment of all stages of Hepatocellular Carcinoma (from intermediate to advanced). And when compared to standard radiation therapy, TARE has fewer side-effects. • Typically TARE is well tolerated. • There may be some transient pain in the upper abdomen. • In very few cases where there is extensive liver involvement there may be a worsening of the liver function and in rare instances an acute liver failure. • However complications are extremely rare, with the incidence of serious complications being less than 1%.

  3. For Hepatocellular Carcinoma patients, Transarterial Radioembolization (TARE) gives better disease control and improves quality of life.

  4. For Hepatocellular Carcinoma patients who cannot get a liver transplant, Transarterial Radioembolization (TARE) has proven to be effective with decrease in tumor size. To know more, Click here

  5. For Hepatocellular Carcinoma patients, Transarterial Radioembolization (TARE) has a higher response rate with longer progression-free survival.

  6. For Hepatocellular Carcinoma patients with inoperable tumors, Transarterial Radioembolization (TARE) can extend lives from months to years.

  7. For more information or a free second opinion about your case. Visit: https://nuclearmedicinetherapy.in/ Email Dr.Ishita Sen at info@nuclearmedicinetherapy.in Call or WhatsappDr.Ishita Sen @ + 91 98111 27080 Address: Nuclear Oncology Department, Fortis Memorial Research Institute (FMRI), Sector 44, Gurgaon, Haryana INDIA

More Related